Complex regions of the human genome remained uncharted, even after researchers sequenced the genome in its entirety. That is, ...

Sarepta faces an “arduous and treacherous path” to try to get its Duchenne muscular dystrophy therapy Elevidys back onto the ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  The House of ...

Improvements in rural cancer care in Kentucky could be imperiled by President Trump's tax and domestic policy bill.

Roche is following its partner Sarepta and halting shipments of the Duchenne gene therapy Elevidys in some countries, amid ...

A digital intervention using the Apple Watch helped people on Medicaid better control their asthma, illustrating the ...

Scientists argue that cane sugar and beef tallow offer no measurable health benefits over corn syrup and vegetable oil, but ...

What if the Trump cost cuts could be used to streamline bureaucracy to actually improve children's access to health care?

A new biotech called Dispatch Bio launched today with the goal of developing a new, universal approach to try to treat any cancer using immunotherapy.

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it deli ...

An experimental oral treatment from Abivax helped ease symptoms in patients with ulcerative colitis, a major win for the ...

A federal report found that an organ procurement organization ignored signs of life in patients when authorizing attempted ...